Zhejiang Agricultural Co., Ltd. (002758): Zhejiang Agricultural Co., Ltd. took the initiative to build an integrated service platform for agricultural materials, automobiles and pharmaceuticals
Huatong Pharmaceutical (002758) In-depth Report: “One aircraft, two wings” is about to take off in the Chinese medicine formula granule policy
Huatong Pharmaceutical (002758) Quarterly report comments: the performance is in the upper limit of the forecast, and the revenue of traditional Chinese medicine formula granules is expected to accelerate significantly from the second quarter.
KuaiBao of Huatong Pharmaceutical (002758) Co., Ltd.: Dingzeng steadily promotes the business of traditional Chinese medicine formula granules is expected to exceed expectations
Comments on Huatong Pharmaceutical (002758) Annual report: the performance of traditional Chinese medicine formula granules is affected in the short term.
Comment on the event of Huatong Pharmaceutical (002758) Co., Ltd.: 16 years' performance is lower than expected. 17 years is the first year of the growth of traditional Chinese medicine formula particles.
Comment on the event of Huatong Pharmaceutical (002758) Company: the non-public offering has been accepted by the Securities Regulatory Commission and the business of traditional Chinese medicine formula granules is progressing smoothly.
[founder Securities] Huatong Pharmaceutical: the non-public offering has been accepted by the CSRC, and the company's traditional Chinese medicine formula granule business is progressing smoothly.
Huatong Pharmaceutical (002758) follow-up report: traditional Chinese medicine formula particles are expected to be fully incorporated into the performance elasticity of health insurance companies in the province.
[founder Securities] Huatong Pharmaceutical: traditional Chinese medicine formula particles are expected to be fully incorporated into health insurance in the province, and the company's performance flexibility has been greatly improved.
Review of the Third Quarterly Report of Huatong Pharmaceutical (002758): The main business is stable and waiting for the release of traditional Chinese medicine formula granules
[Southwest Securities] Huatong Pharmaceutical: The main business is stable, waiting for the release of traditional Chinese medicine formula granules
Huatong Pharmaceutical (002758) Quarterly Report Review: The results of the third quarter report are in line with expectations. Starting in the fourth quarter, traditional Chinese medicine formula granules will significantly increase the company's perform
[Fangzheng Securities] Huatong Pharmaceutical: The results of the third quarter report are in line with expectations. Starting in the fourth quarter, traditional Chinese medicine formula granules will significantly increase the company's performance
Huatong Pharmaceutical (002758) Research Report: The Chinese medicine tablet and formula business is progressing step by step and has a solid foundation in the commercial sector
Huatong Pharmaceutical (002758) Follow-up Report: An Underrated Regional Leading Company in Traditional Chinese Medicine Formulation Granules
[Fangzheng Securities] Huatong Pharmaceutical: A regional leading underrated Chinese medicine formula granule company
[Huatai Securities] Huatong Pharmaceutical: Pricing Report for the First Day of Listing on May 27
华通医药(002758):5月27日上市首日定价报告
[Hengtai Securities] Huatong Pharmaceutical: The initial stock price pressure level of the company's initial listing is expected to be 42 yuan to 45 yuan
No Data